Study on Clostridium Difficile Infection in Infants

  • STATUS
    Recruiting
  • End date
    Dec 30, 2026
  • participants needed
    150
  • sponsor
    First People's Hospital of Hangzhou
Send
Updated on 3 March 2025
See if I qualify

Summary

This study aims to investigate the epidemiological characteristics and biomarkers of Clostridium difficile infection in infants . By analyzing historical medical data and patient questionnaires, this retrospective cohort study will identify potential high-risk factors and establish baseline biomarkers to improve diagnosis and treatment for affected patients.

Description

This retrospective cohort study focuses on Clostridium difficile infection (CDI) in infants n, a relatively rare infection. The study will utilize data from hospital and community to identify the prevalence, risk factors, and unique biomarkers associated with CDI in pediatric patients. Key objectives include: (1) analyzing demographic and clinical characteristics of affected patients, (2) evaluating the high-risk factors of CDI, and (3) identifying biomarkers that can aid in early detection and treatment planning. Findings from this study are expected to contribute to the improvement of CDI management in pediatric care.

Details
Condition Clostridium Difficile Infection
Age 24months or below
Clinical Study IdentifierNCT06703918
SponsorFirst People's Hospital of Hangzhou
Last Modified on3 March 2025

Eligibility

 Yes No Not Sure

Inclusion Criteria

Infants ( aged 0-2 years). Medical records and patient questionnaires available with confirmed Clostridium difficile infection (for case group) or without infection (for control group)

Exclusion Criteria

Infants beyond the age of 2 years at the time of diagnosis. Incomplete medical records or missing essential information related to infection status, feeding methods, or antibiotic exposure.Patients with other severe gastrointestinal conditions that may confound results
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.56
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.57
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.58
Sign up59

Send a message24

Enter your contact details to connect with study team25

Investigator Avatar

Primary Contact26

First name*27
Last name*30
Email*33
Phone number*37
Preferred way of contact label
Race
Ethnicity
Other language43

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.